Agios Pharmaceuticals Ownership | Who Owns Agios Pharmaceuticals?
Agios Pharmaceuticals Ownership Summary
Agios Pharmaceuticals is owned by 101.73% institutional investors, 1.51% insiders. Farallon capital management is the largest institutional shareholder, holding 9.95% of AGIO shares. BB Biotech AG Ord is the top mutual fund, with 6.16% of its assets in Agios Pharmaceuticals shares.
AGIO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Agios Pharmaceuticals | 101.73% | 1.51% | -3.24% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Farallon capital management | 5.65M | 9.95% | $243.82M |
Vanguard group | 5.63M | 9.89% | $185.05M |
Blackrock funding, inc. /de | 5.02M | 8.81% | $164.83M |
Blackrock | 4.86M | 8.55% | $209.52M |
Bellevue group | 3.88M | 6.83% | $167.29M |
Price t rowe associates inc /md/ | 2.78M | 4.89% | $119.76M |
State street | 2.11M | 3.72% | $91.20M |
Armistice capital | 2.08M | 3.66% | $89.65M |
Macquarie group | 1.68M | 2.96% | $55.37M |
Geode capital management | 1.35M | 2.37% | $44.36M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Caligan partners lp | 514.71K | 5.19% | $22.19M |
Bellevue group | 3.88M | 2.72% | $167.29M |
Eagle health investments lp | 330.83K | 2.67% | $10.87M |
Parkman healthcare partners | 446.42K | 2.58% | $19.25M |
Frazier life sciences management | 871.97K | 1.76% | $37.60M |
Bvf inc/il | 1.19M | 1.44% | $51.32M |
Rock springs capital management lp | 1.04M | 1.36% | $45.03M |
Farallon capital management | 5.65M | 1.15% | $243.82M |
Armistice capital | 2.08M | 1.13% | $89.65M |
Centerbook partners lp | 305.60K | 0.60% | $10.04M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bvf inc/il | 1.19M | 1.44% | 1.19M |
Price t rowe associates inc /md/ | 2.78M | 0.01% | 764.27K |
Schonfeld strategic advisors | 464.12K | 0.13% | 464.12K |
Parkman healthcare partners | 446.42K | 2.58% | 446.42K |
Frazier life sciences management | 871.97K | 1.76% | 348.81K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
State street | 2.11M | 0.00% | -1.02M |
T. rowe price investment management | - | - | -928.60K |
Armistice capital | 2.08M | 1.13% | -884.85K |
Rock springs capital management lp | 1.04M | 1.36% | -720.24K |
Jpmorgan chase | 1.02M | 0.00% | -697.63K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Bvf inc/il | 1.19M | 1.44% | 1.19M | $51.32M |
Schonfeld strategic advisors | 464.12K | 0.13% | 464.12K | $20.01M |
Parkman healthcare partners | 446.42K | 2.58% | 446.42K | $19.25M |
Norges bank | 145.09K | 0.00% | 145.09K | $4.77M |
Granahan investment management | 136.84K | 0.24% | 136.84K | $5.90M |
Sold Out
Holder | Change |
---|---|
National bank of canada /fi/ | -1.00 |
Riverview trust | -11.00 |
Nelson, van denburg & campbell wealth management group | -11.00 |
Covestor | -12.00 |
Innealta capital | -17.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 222 | 1.83% | 57,925,704 | 3.66% | 101 | 1.05% | 104 | 1.96% | 66 | -15.38% |
Jun 30, 2024 | 218 | 9.00% | 55,883,066 | -6.01% | 98 | 0.88% | 102 | -0.97% | 78 | 39.29% |
Mar 31, 2024 | 200 | 11.73% | 59,453,348 | 2.90% | 105 | 0.98% | 103 | 9.57% | 56 | 12.00% |
Dec 31, 2023 | 179 | 15.48% | 57,776,522 | 1.07% | 103 | 0.99% | 94 | 40.30% | 50 | 6.38% |
Sep 30, 2023 | 155 | -4.91% | 57,163,101 | -0.88% | 102 | 0.95% | 67 | -17.28% | 47 | 6.82% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
BB Biotech AG Ord | 3.52M | 6.16% | -220.76K |
Vanguard Total Stock Mkt Idx Inv | 1.77M | 3.10% | 1.92K |
iShares Russell 2000 ETF | 1.54M | 2.69% | -11.70K |
Vanguard Small Cap Index | 1.45M | 2.55% | 17.99K |
Delaware Small Cap Core I | 1.38M | 2.42% | -8.55K |
Macquarie Small Cap Core I | 1.38M | 2.42% | - |
T. Rowe Price Health Sciences | 982.82K | 1.72% | -401.20K |
Vanguard Institutional Extnd Mkt Idx Tr | 869.08K | 1.52% | 17.62K |
Vanguard Small Cap Growth Index Inv | 825.42K | 1.45% | 36.70K |
DWS Vermögensbildungsfonds I LD | 805.53K | 1.41% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 05, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | $78.13K |
Jan 06, 2025 | Milanova Tsveta | Chief Commercial Officer | Sell | $90.23K |
Dec 11, 2024 | Scadden David | - | Sell | $9.26K |
Nov 08, 2024 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | $43.30K |
Nov 08, 2024 | Ballal Rahul D. | - | Sell | $288.69K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 2 |
2024 Q4 | - | 9 |
2024 Q3 | - | 3 |
2024 Q2 | - | 3 |
2024 Q1 | - | 31 |
AGIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools